FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Real-time Boerse Frankfurt Warrants 12:41:29 2024-06-14 pm EDT | ||
| 1.3 EUR | 0.00% |
|
| Current month | -8.45% | ||
| 1 month | -0.76% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 1.3 | 0.00% |
| 24-06-13 | 1.3 | +4.00% |
| 24-06-12 | 1.25 | +2.46% |
| 24-06-11 | 1.22 | -0.81% |
| 24-06-10 | 1.23 | -1.60% |
Real-time Boerse Frankfurt Warrants
Last update June 14, 2024 at 12:41 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Société Générale
|
| WKN | SF5DRG |
| ISIN | DE000SF5DRG6 |
| Date issued | 2021-10-06 |
| Strike | 83.16 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.05 € |
|---|---|
| Lowest since issue | 1.19 € |
| Spread | 0.01 € |
| Spread % | 0.76% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.4
USD
Average target price
142.7
USD
Spread / Average Target
+10.29%
- Stock Market
- Certificates
- Certificat
